ApprovalTrail

Approval · Notice of Compliance 6924 · 1998

STATUS 100 INJECTABLE SOLUTION: Notice of Compliance 6924

Issued March 20, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6924
Date
March 20, 1998
Company
Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
STATUS 100 INJECTABLE SOLUTION02237561—

Medicinal ingredients